We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

166 hedge funds and large institutions have $1.9B invested in Medicines Co in 2014 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

64% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 25

25% more capital invested

Capital invested by funds: $1.52B → $1.9B (+$382M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9% more funds holding

Funds holding: 152 → 166 (+14)

51% less call options, than puts

Call options by funds: $6.41M | Put options by funds: $13M

Holders
166
Holders Change
+14
Holders Change %
+9.21%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
41
Increased
57
Reduced
50
Closed
25
Calls
$6.41M
Puts
$13M
Net Calls
-$6.59M
Net Calls Change
+$4.63M

Top Buyers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
+$33.1M
2
FCM
Frontier Capital Management
Massachusetts
+$32.9M
3
CCM
Camber Capital Management
Massachusetts
+$32.7M
4
Citadel Advisors
Citadel Advisors
Florida
+$19.1M
5
BFA
BlackRock Fund Advisors
California
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$71.2M
2
RA
Royce & Associates
New York
-$51.6M
3
PI
Putnam Investments
Massachusetts
-$16.7M
4
CCP
Clough Capital Partners
Massachusetts
-$15.9M
5
SPC
Slate Path Capital
New York
-$9.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
51
EverPoint Asset Management
Connecticut
$5.53M +$4.96M +200,000 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$4.44M -$89.2K -3,600 -2%
MSA
53
Mason Street Advisors
Wisconsin
$4.35M +$7.51K +303 +0.2%
GC
54
Guggenheim Capital
Illinois
$4.34M -$613K -24,757 -14%
QI
55
QS Investors
New York
$4.3M +$3.85M +155,403 New
Prudential Financial
56
Prudential Financial
New Jersey
$4.09M +$96.6K +3,900 +3%
NFA
57
Nationwide Fund Advisors
Ohio
$4.07M -$72.4K -2,922 -2%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$3.65M – – –
KAM
59
Krensavage Asset Management
New York
$3.56M +$3.19M +128,600 New
Comerica Bank
60
Comerica Bank
Texas
$3.51M +$1.55M +62,695 +98%
Caisse de Depot et Placement du Quebec (CDPQ)
61
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$3.46M +$3.1M +125,000 New
Public Sector Pension Investment Board (PSP Investments)
62
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.4M +$27.3K +1,100 +0.9%
Macquarie Group
63
Macquarie Group
Australia
$3.37M -$528K -21,327 -15%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$3.35M +$27.6K +1,113 +0.9%
Bank of America
65
Bank of America
North Carolina
$3.28M -$1.05M -42,349 -26%
IAS
66
IMA Advisory Services
Colorado
$3.01M +$31.7K +1,280 +1%
PRCM
67
Pine River Capital Management
Minnesota
$2.83M +$2.54M +102,345 New
CC
68
CQS Cayman
Cayman Islands
$2.77M +$2.48M +100,000 New
SFM
69
Sphera Funds Management
Israel
$2.77M +$2.48M +100,000 New
PPA
70
Parametric Portfolio Associates
Washington
$2.66M +$327K +13,194 +16%
PAM
71
Paradigm Asset Management
New York
$2.64M – – –
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
$2.64M +$1.41M +57,086 +149%
CCMH
73
Cornerstone Capital Management Holdings
New York
$2.57M -$758K -30,600 -25%
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$2.5M +$502K +20,282 +29%
AP
75
AHL Partners
United Kingdom
$2.36M +$2.11M +85,232 New
1 2
3
4 5

MDCO Hedge Fund Activity: Q4 2014 in Review

166 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2014, worth a combined $1.9B — up 25% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MDCO positions and 25 closed out — a net gain of 16 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was PointState Capital, adding an estimated $33.1M. The largest seller was Fidelity Investments, cutting an estimated $71.2M.

  • 166 institutional investors held Medicines Co (MDCO) as of Q4 2014, up from 152 in Q3 2014.
  • Funds reported $1.9B of Medicines Co stock for Q4 2014, up 25% quarter-over-quarter.
  • 41 funds opened new Medicines Co positions in Q4 2014 and 25 closed out, a net change of +16 holders.
  • The largest Medicines Co buyer in Q4 2014 was PointState Capital, an estimated $33.1M added.
  • The largest Medicines Co seller in Q4 2014 was Fidelity Investments, an estimated $71.2M sold.

Based on aggregated 13F filings for Q4 2014.